Published in Ann Rheum Dis on March 01, 1995
The combined role of wear particles, macrophages and lymphocytes in the loosening of total joint prostheses. J R Soc Interface (2008) 1.32
Modulation of the phenotypic and functional properties of phagocytic macrophages by wear particles from orthopaedic implants. J Mater Sci Mater Med (1997) 1.04
Extracellular matrix of the synovial intimal cell layer. Ann Rheum Dis (1995) 1.04
Interleukin 15 production by macrophages in the implant interface membrane of aseptically loosened joint replacements. J Mater Sci Mater Med (1998) 0.86
Extracellular matrix degradation and tissue remodeling in periprosthetic loosening and osteolysis: focus on matrix metalloproteinases, their endogenous tissue inhibitors, and the proteasome. Biomed Res Int (2013) 0.85
Direct activation of mast cells by prosthetic biomaterial particles. J Mater Sci Mater Med (1998) 0.81
The expression of CD44 in archival paraffin embedded interface tissues of failed orthopaedic implants. J Mater Sci Mater Med (2004) 0.78
Protection against titanium particle-induced inflammatory osteolysis by the proteasome inhibitor bortezomib in vivo. Inflammation (2012) 0.78
Evidence for active antigen presentation by monocyte/macrophages in response to stimulation with particles: the expression of NFκB transcription factors and costimulatory molecules. Inflammopharmacology (2013) 0.77
Effects of SU5416 and a vascular endothelial growth factor neutralizing antibody on wear debris-induced inflammatory osteolysis in a mouse model. J Inflamm Res (2011) 0.77
Does a pro-angiogenic state exist in the bone-implant interface of aseptically loosened joint prosthesis? J Mater Sci Mater Med (2004) 0.76
Increased expression of inducible co-stimulator on CD4+ T-cells in the peripheral blood and synovial fluid of patients with failed hip arthroplasties. Bone Joint Res (2016) 0.75
How has the introduction of new bearing surfaces altered the biological reactions to byproducts of wear and modularity? Clin Orthop Relat Res (2014) 0.75
Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science (1989) 10.70
Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci U S A (1987) 10.43
Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell (1989) 9.06
VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell (1990) 8.87
Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. J Clin Invest (1985) 8.70
Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol (1986) 8.22
A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol (1986) 7.71
ELAM-1 is an adhesion molecule for skin-homing T cells. Nature (1991) 5.12
Leukocyte adhesion to endothelium in inflammation. Cell (1990) 4.47
Induction and detection of a human endothelial activation antigen in vivo. J Exp Med (1986) 3.66
The role of endothelial cells in inflammation. Transplantation (1990) 3.47
Activation-independent binding of human memory T cells to adhesion molecule ELAM-1. Nature (1991) 3.45
ICAM-1 a ligand for LFA-1-dependent adhesion of B, T and myeloid cells. Nature (1988) 3.12
Vascular and nonvascular expression of INCAM-110. A target for mononuclear leukocyte adhesion in normal and inflamed human tissues. Am J Pathol (1991) 2.98
Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med (1991) 2.76
Roles of adhesion molecules in T-cell recognition: fundamental similarities between four integrins on resting human T cells (LFA-1, VLA-4, VLA-5, VLA-6) in expression, binding, and costimulation. Immunol Rev (1990) 2.68
Immunolocalization of endothelial and leukocyte adhesion molecules in human rheumatoid and osteoarthritic synovial tissues. Lab Invest (1991) 2.59
A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1, or lipopolysaccharide. J Immunol (1990) 2.55
Membrane proteins involved in phagocyte adherence to endothelium. Immunol Rev (1990) 2.30
The synovial-like membrane at the bone-cement interface in loose total hip replacements and its proposed role in bone lysis. J Bone Joint Surg Am (1983) 2.28
T lymphocyte adhesion to endothelial cells: mechanisms demonstrated by anti-LFA-1 monoclonal antibodies. J Immunol (1986) 2.28
Four molecular pathways of T cell adhesion to endothelial cells: roles of LFA-1, VCAM-1, and ELAM-1 and changes in pathway hierarchy under different activation conditions. J Cell Biol (1991) 2.27
Intercellular adhesion molecule 1 (ICAM-1) has a central role in cell-cell contact-mediated immune mechanisms. Proc Natl Acad Sci U S A (1988) 2.08
Metal sensitivity as a cause of bone necrosis and loosening of the prosthesis in total joint replacement. J Bone Joint Surg Br (1974) 1.94
Supergene families meet in the immune system. Immunol Today (1989) 1.78
The role of the LFA-1/ICAM-1 interaction in human leukocyte homing and adhesion. Immunol Rev (1989) 1.75
Inducible expression of class II major histocompatibility complex antigens and the immunogenicity of vascular endothelium. Transplantation (1986) 1.64
Differential distribution of intercellular adhesion molecules (ICAM-1, ICAM-2, and ICAM-3) and the MS-1 antigen in normal and diseased human synovia. Their possible pathogenetic and clinical significance in rheumatoid arthritis. Arthritis Rheum (1994) 1.64
The VLA-4/VCAM-1 pathway is involved in lymphocyte adhesion to endothelium in rheumatoid synovium. J Immunol (1991) 1.63
Endothelial leucocyte adhesion molecule-1 (ELAM-1) expression in cutaneous inflammation. Br J Dermatol (1991) 1.57
Expression of vascular cell adhesion molecule-1 in normal and inflamed synovium. Lab Invest (1993) 1.50
Immunohistologic analysis of the distribution of cell adhesion molecules within the inflammatory synovial microenvironment. Arthritis Rheum (1989) 1.47
The expression of endothelial leukocyte adhesion molecule-1 (ELAM-1), intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in experimental cutaneous inflammation: a comparison of ultraviolet B erythema and delayed hypersensitivity. J Invest Dermatol (1991) 1.37
Metal sensitivity in patients with joint replacement arthroplasties. Br Med J (1975) 1.34
Expression of I-region-associated antigen (Ia) and interleukin 1 by subcultured human endothelial cells. Cell Immunol (1985) 1.33
What can be learned from the expression of endothelial adhesion molecules in tissues? Lab Invest (1991) 1.19
Modulation of leucocyte adhesion molecules, a T-cell chemotaxin (IL-8) and a regulatory cytokine (TNF-alpha) in allergic contact dermatitis (rhus dermatitis). Br J Dermatol (1991) 1.14
Formation of a synovial-like membrane at the bone-cement interface. Its role in bone resorption and implant loosening after total hip replacement. Arthritis Rheum (1986) 1.12
Regulation of expression of a human intercellular adhesion molecule (ICAM-1) during lymphohematopoietic differentiation. Blood (1989) 1.08
Interleukin-1 production by activated macrophages surrounding loosened orthopaedic implants: a potential role in osteolysis. Br J Rheumatol (1994) 1.01
Bone lysis in well-fixed cemented femoral components. J Bone Joint Surg Br (1990) 1.01
The role of leukocyte adhesion molecules in cellular interactions: implications for the pathogenesis of inflammatory synovitis. Springer Semin Immunopathol (1989) 0.91
Cloned stromal cell lines derived from human Whitlock/Witte-type long-term bone marrow cultures. Exp Hematol (1990) 0.88
Immunopathological response to loose cementless acetabular components. J Bone Joint Surg Br (1991) 0.86
Intercellular adhesion molecules in normal synovium. Br J Rheumatol (1993) 0.84
Role of the CS1 adhesion motif of fibronectin in T cell adhesion to synovial membrane and peripheral lymph node endothelium. Ann Rheum Dis (1993) 0.78
Presence of macrophages at the bone-cement interface of stable hip arthroplasty components. Acta Orthop Scand (1987) 0.78
Extensive osteolysis behind an acetabular component that was well fixed with cement. A case report. J Bone Joint Surg Am (1993) 0.77
Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage (2005) 6.77
Resorption of bone by isolated rabbit osteoclasts. J Cell Sci (1984) 2.33
A comparative study by morphometry of the microvasculature in normal and rheumatoid synovium. Arthritis Rheum (1991) 2.18
Bone anatomy and rotational alignment in total knee arthroplasty. Clin Orthop Relat Res (2002) 1.98
Histomorphometry of bone. J Clin Pathol (1983) 1.71
The production and biology of polyethylene wear debris. Arch Orthop Trauma Surg (1978) 1.65
Synovial pathology in Behcet's syndrome. Ann Rheum Dis (1978) 1.54
Substance P-, calcitonin gene-related peptide- and C-flanking peptide of neuropeptide Y-immunoreactive fibres are present in normal synovium but depleted in patients with rheumatoid arthritis. Neuroscience (1990) 1.49
A comparative study on the in vivo behavior of hydroxyapatite and silicon substituted hydroxyapatite granules. J Mater Sci Mater Med (2002) 1.42
Sensitivity to titanium. A cause of implant failure? J Bone Joint Surg Br (1991) 1.39
Bone formation and bone resorption in failed total joint arthroplasties: histomorphometric analysis with histochemical and immunohistochemical technique. J Orthop Res (1996) 1.38
Role of mesenchymal nidogen for epithelial morphogenesis in vitro. Development (1994) 1.36
Mononuclear phagocytes of normal and rheumatoid synovial membrane identified by monoclonal antibodies. Immunology (1985) 1.33
The composition of normal and osteoarthritic articular cartilage from human knee joints. With special reference to unicompartmental replacement and osteotomy of the knee. J Bone Joint Surg Am (1984) 1.32
Tibiofemoral movement 3: full flexion in the living knee studied by MRI. J Bone Joint Surg Br (2000) 1.31
Histopathology of the synovial membrane of peripheral joints in ankylosing spondylitis. Ann Rheum Dis (1982) 1.31
Apoptosis--a significant cause of bone cell death in osteonecrosis of the femoral head. J Bone Joint Surg Br (2004) 1.29
The myocardium in ankylosing spondylitis. A clinical, echocardiographic, and histopathological study. Lancet (1987) 1.27
Features of synovial membrane identified with monoclonal antibodies. Clin Exp Immunol (1985) 1.25
Bilateral avascular necrosis of the capitate. A case report and a review of the literature. J Bone Joint Surg Br (1984) 1.24
Proliferative activity of cells in the synovium as demonstrated by a monoclonal antibody, Ki67. Rheumatol Int (1987) 1.22
A role for IL-1 alpha in inducing pathologic inflammation during bacterial infection. Proc Natl Acad Sci U S A (2001) 1.22
Anthropometry of the proximal tibia to design a total knee prosthesis for the Japanese population. J Arthroplasty (2002) 1.17
Proteoglycans of the intervertebral disc. Homology of structure with laryngeal proteoglycans. Biochem J (1979) 1.15
Examination of synovial fluid. Curr Top Pathol (1982) 1.14
Hydrogels as an interface between bone and an implant. Biomaterials (1993) 1.13
Type IV collagen and laminin in the synovial intimal layer: an immunohistochemical study. Rheumatol Int (1990) 1.10
Observations upon the interface between bone and polymethylmethacrylate cement. J Bone Joint Surg Br (1982) 1.10
A monoclonal antibody (Mab 67) marks type B synoviocytes. Rheumatol Int (1990) 1.07
Fibronectin production by synovial intimal cells. Rheumatol Int (1985) 1.06
Modulation of the phenotypic and functional properties of phagocytic macrophages by wear particles from orthopaedic implants. J Mater Sci Mater Med (1997) 1.04
Inhibition of macrophage migration by a proteoglycan extracted from Kurloff cells of the guinea-pig. Int Arch Allergy Appl Immunol (1972) 1.04
Incidence of metabolic bone disease in rheumatoid arthritis and osteoarthritis. Ann Rheum Dis (1984) 1.04
The flexion gap in normal knees. An MRI study. J Bone Joint Surg Br (2004) 1.04
Tissue reactions to joint prostheses and the products of wear and corrosion. Curr Top Pathol (1982) 1.03
Microporosity enhances bioactivity of synthetic bone graft substitutes. J Mater Sci Mater Med (2005) 1.03
Wear particulate species and bone loss in failed total joint arthroplasties. Clin Orthop Relat Res (1997) 1.03
The effect of hydroxyapatite coating on ingrowth of bone into cavities in an implant. J Arthroplasty (1991) 1.03
Number of polyethylene particles and osteolysis in total joint replacements. A quantitative study using a tissue-digestion method. J Bone Joint Surg Br (1997) 1.01
Lymphocytes, polymorphonuclear leukocytes, macrophages and platelets in synovium involved by rheumatoid arthritis. A study with monoclonal antibodies. Pathology (1986) 1.01
Interleukin-1 production by activated macrophages surrounding loosened orthopaedic implants: a potential role in osteolysis. Br J Rheumatol (1994) 1.01
Gamma-irradiated cross-linked polyethylene in total hip replacements--analysis of retrieved sockets after long-term implantation. J Biomed Mater Res (2001) 1.00
In vivo skeletal response and biomechanical assessment of two novel polyalkenoate cements following femoral implantation in the female New Zealand White rabbit. J Mater Sci Mater Med (1998) 0.99
Constituents and pH changes in protein rich hyaluronan solution affect the biotribological properties of artificial articular joints. J Biomech (2001) 0.99
The excretion and degradation of chondroitin 4-sulphate administered to guinea pigs as free chondroitin sulphate and as proteoglycan. Biochem J (1972) 0.98
Studies on the effect of cyclophosphamide on T and B lymphocytes in the blood, lymph nodes, and thymus of normal guinea pigs. Int Arch Allergy Appl Immunol (1974) 0.98
The expression of osteoclast markers on foreign body giant cells. Bone Miner (1994) 0.98
Synovial lining cell hyperplasia in rheumatoid arthritis: dogma and fact. Ann Rheum Dis (1988) 0.98
Relationships between biosolids treatment process and soil phosphorus availability. J Environ Qual (2001) 0.97
The distribution and ultrastructure of the Kurloff cell in the guinea-pig. J Anat (1971) 0.97
Extraordinary carrier multiplication gated by a picosecond electric field pulse. Nat Commun (2011) 0.94
The extent of osteocyte death in the proximal femur of patients with osteonecrosis of the femoral head. J Bone Joint Surg Br (2001) 0.94
Total hip arthroplasty with a modified cementing technique using hydroxyapatite granules. J Arthroplasty (2001) 0.94
Studies on the function of the Kurloff cell. Int Arch Allergy Appl Immunol (1971) 0.94
Populations of guinea pig lymphocytes and Kurloff cells characterised by rosette-forming reactions. Int Arch Allergy Appl Immunol (1974) 0.94
Resurfacing arthroplasty. Femoral head viability. Clin Orthop Relat Res (1987) 0.93
Quantification of bone ingrowth within bone-derived porous hydroxyapatite implants of varying density. J Mater Sci Mater Med (2004) 0.92
Pathology of the bone-implant interfaces. J Long Term Eff Med Implants (1999) 0.92
The immunocytochemical demonstration of basement membrane deposition in transitional cell carcinoma of bladder. Virchows Arch A Pathol Anat Histopathol (1989) 0.91
Ultrastructural localisation of muramidase in the human synovial membrane. Ann Rheum Dis (1987) 0.91
The size and shape of particulate polyethylene wear debris in total joint replacements. Proc Inst Mech Eng H (1997) 0.91
Remodelling of subchondral bone in osteoarthritis: a histomorphometric study. J Clin Pathol (1992) 0.91
The fixation of a proximal tibial polyethylene prosthesis without cement. J Bone Joint Surg Br (1982) 0.89
Nitric oxide synthase is expressed in human macrophages during foreign body inflammation. Am J Pathol (1997) 0.89
Anteroposterior and rotational movement of femur during knee flexion. Clin Orthop Relat Res (1999) 0.89
Costimulatory molecule expression following exposure to orthopaedic implants wear debris. J Biomed Mater Res (2001) 0.89
Ultrastructural characterisation of macrophages (type A cells) in the synovial lining. Rheumatol Int (1988) 0.88
Biomechanical assessment of bone ingrowth in porous hydroxyapatite. J Mater Sci Mater Med (1997) 0.87
Hydroxyapatite granules interposed at bone-cement interface in total hip replacements: histological study of retrieved specimens. J Biomed Mater Res (2000) 0.87
Localisation and characterisation of substance P binding to human synovial tissue in rheumatoid arthritis. Ann Rheum Dis (1992) 0.87
Fibronectin in the synovium of chronic inflammatory joint disease. Rheumatol Int (1984) 0.87
Real-time terahertz near-field microscope. Opt Express (2011) 0.86
The simultaneous presentation of Hodgkin's disease of myeloma. Postgrad Med J (1977) 0.86
Evaluation of the flexion gap by axial radiography of the distal femur. J Bone Joint Surg Br (2006) 0.85
Phenotypic characteristics of T lymphocytes in the interfacial tissue of aseptically loosened prosthetic joints. J Mater Sci Mater Med (2004) 0.84
Immunohistochemical localization of two types of carbonic anhydrase isozymes in oncocytoma and oncocytic epithelial cells. Osaka City Med J (1989) 0.83
Wear of high-dose gamma-irradiated polyethylene in total hip replacements. J Orthop Sci (2000) 0.83
How does higher ultrafiltration within the conventional clinical range impact the volume status of hemodialysis patients? Blood Purif (2009) 0.83
An immunocytochemical study of the distribution of proline-4-hydroxylase in normal, osteoarthritic and rheumatoid arthritic synovium at both the light and electron microscopic level. Br J Rheumatol (1998) 0.83
Re: Apparent staining of mast cells for fibronectin with a peroxidase-antiperoxidase method on formalin fixed sections. J Immunol Methods (1984) 0.82
Production and distribution of interleukin 15 and its receptors (IL-15Ralpha and IL-R2beta) in the implant interface tissues obtained during revision of failed total joint replacement. Int J Exp Pathol (2001) 0.82
Kurloff cell levels in the peripheral blood of normal and oestrogen treated guinea-pigs. Br J Exp Pathol (1974) 0.82
Direct activation of mast cells by prosthetic biomaterial particles. J Mater Sci Mater Med (1998) 0.81
The Kurloff cell. Int Rev Cytol (1977) 0.81
Ultrasound has no anti-inflammatory effect. Ann Rheum Dis (1983) 0.81
Significant role of laminin-1 in branching morphogenesis of mouse salivary epithelium cultured in basement membrane matrix. Dev Growth Differ (1999) 0.81
The mechanical properties of cement and loosening of the femoral component of hip replacements. J Bone Joint Surg Br (1987) 0.81
Homograft bone in revision acetabular arthroplasty. A clinical and radiographic study. J Bone Joint Surg Br (1988) 0.81
The relationship between osteonecrosis of the proximal femur identified by MRI and lesions proven by histological examination. J Bone Joint Surg Br (2008) 0.80
Isolation of a novel carbonic anhydrase from human saliva and immunohistochemical demonstration of its related isozymes in salivary gland. Osaka City Med J (1987) 0.80
Integrin expression at the bone/biomaterial interface. J Biomed Mater Res (2001) 0.80
ICLH double-cup arthroplasty, 1980-1987. J Arthroplasty (1990) 0.80
Immunohistochemical analysis of mononuclear cell subsets in inflammatory and non-inflammatory myopathies. J Clin Pathol (1986) 0.80
Analysis of push-out test data based on interfacial fracture energy. J Mater Sci Mater Med (1999) 0.79
Malignant histiocytosis with associated "reticulum celled sarcoma". J Pathol (1977) 0.79
Assessment of the role of GM-CSF in the cellular transformation and the development of erosive lesions around orthopaedic implants. Am J Clin Pathol (1996) 0.79